Medicine & Life Sciences
Anti-Bacterial Agents
100%
India
81%
Carbapenems
62%
Microbial Drug Resistance
51%
Income
46%
Coronavirus
40%
Antimicrobial Stewardship
35%
Infections
29%
Delivery of Health Care
26%
Cross Infection
25%
Cephalosporins
25%
Pandemics
24%
SARS Virus
24%
Escherichia coli
23%
Methicillin
20%
Klebsiella pneumoniae
19%
Observational Studies
19%
Severe Acute Respiratory Syndrome
18%
Retrospective Studies
17%
Staphylococcus aureus
17%
Bacteria
17%
Antibiotic Prophylaxis
17%
Primary Health Care
17%
Infection Control
17%
Meta-Analysis
17%
Systematic Reviews
17%
Methicillin-Resistant Staphylococcus aureus
15%
Neonatal Intensive Care Units
15%
Confidence Intervals
15%
Prescriptions
14%
Interrupted Time Series Analysis
14%
Acinetobacter baumannii
13%
fropenem
13%
Guidelines
13%
Public Health
13%
Coronavirus Infections
13%
Neonatal Sepsis
13%
Gold
12%
Pharmaceutical Preparations
12%
Logistic Models
12%
Child
12%
Colistin
11%
Pseudomonas aeruginosa
11%
Tertiary Healthcare
10%
Microbiology
10%
Vancomycin-Resistant Enterococci
10%
Carbapenem-Resistant Enterobacteriaceae
10%
Nucleic Acid Amplification Techniques
10%
Odds Ratio
10%
Public Facilities
10%
Social Sciences
sales
14%
income
11%
India
10%
clinical outcomes
9%
hospital care
9%
secondary analysis
7%
hygiene
7%
socioeconomic factors
7%
health care
7%
ban
7%
Kenya
7%
surveillance
6%
mortality
6%
everyday life
6%
data analysis
5%